Freeze-drying of itraconazole-loaded nanosphere suspensions: A feasibility study

Drug Development Research

Volumn 38, Issue 2, 1996, Pages 116-124

  De Chasteigner, Stéphanie ^a   Cavé, Guy ^b   Fessi, Hatem ^c   Devissaguet, Jean Philippe ^a   Puisieux, Francis ^a  

^a UNIV PARIS SUD   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Cryoprotection; Freeze drying; Itraconazole; Nanospheres; Poly caprolactone

Indexed keywords

CRYOPROTECTIVE AGENT; DEXTRAN; DRUG CARRIER; ITRACONAZOLE; MANNITOL; NANOPARTICLE; NONIONIC SURFACTANT; POLOXAMER; POLYMER; SUCROSE; TREHALOSE; TRIAZOLE DERIVATIVE;

ADSORPTION; ARTICLE; CRYOPROTECTION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; FREEZE DRYING; PARTICLE SIZE; SURFACE CHARGE; SURFACE PROPERTY; SUSPENSION;

EID: 0029803268     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199606)38:2<116::AID-DDR6>3.3.CO;2-R     Document Type: Article

References (41)

1. Auvillain M, Cave G, Fessi H, Devissaguet J-P (1989): Lyophilisation de vecteurs colloïdaux submicroniques. STP Pharmcoea 5:738-744.
2. Bakker-Woudenberg IAJM, Roerdink FH (1986): Antimicrobial chemotherapy directed by liposomes. J Antimicrob Chemother 17:547-548.
3. Bakker-Woudenberg IAJM, Lokerse AF, ten Kate MT, Melissen PMB, Van Vianen W, Van Etten EWM (1993): Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections. Eur J Clin Microbiol Infect Dis 12:61-67.
4. Bakker-Woudenberg IAJM, Storm G, Woodle MC (1994): Liposomes in the treatment of infections. J Drug Target 2:363-371.
5. Brasseur R, Goormaghtigh E, Ruysschaert J-M, Duquenoy P-H, Marichal P, Vanden Bossche H (1991): Lipid-itraconazole interaction in lipid model membranes. J Pharm Pharmacol 43:167-171.
6. Clemons KV, Homola ME, Stevens DA (1995): Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother 39:1169-1172.
7. Como JA, Dismukes WE (1994): Oral azole drugs as systemic antifungal therapy. New Engl J Med 330:263-272.
8. Crowe JH, Crowe LM, Chapman D (1984a): Preservation of membranes in anydrobiotic organisms: The role of trehalose. Science 223:701-703.
9. Crowe JH, Whittam MA, Chapman D, Crowe LM (1984b): Interactions of phospholipid monolayers with carbohydrates. Biochim Biophys Acta 769:151-159.
10. Crowe LM, Crowe JH, Chapman D (1985a): Interaction of carbohydrates with dry dipalmitoylphosphatidylcholine. Arch Biochem Biophys 236:289-296.
11. Crowe LM, Crowe JH, Rudolph A, Womersley C, Appel L (1985b): Preservation of freeze-dried liposomes by trehalose. Arch Biochem Biophys 242:240-247.
12. Crowe JH, Crowe LM, Carpenter JF, Aurell Wistrom C (1987a): Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem J 242:1-10.
13. Crowe JH, Spargo BJ, Crowe LM (1987b): Preservation of dry liposomes does not require retention of residual water. Proc Natl Acad Sci USA 84:1537-1540.
14. de Chasteigner S, Fessi H, Cave G, Devissaguet J-P., Puisieux F (1995): Gastro-intestinal tolerance study of a freeze-dried oral dosage form of indomethacin-loaded nanocapsules. STP Pharma Sci 5:242-246.
15. de Chasteigner S, Fessi H, Devissaguet J-P, Puisieux F (1996): A comparative study of the association of itraconazole within colloidal drug carrier systems. Drug Dev Res (in press).
16. Dismukes WE (1988): Azole antifungal drugs: Old and new. Ann Intern Med 109:177-179.
17. Elimelech M, O'Melia CR (1990): Effect of particle size on collision efficiency in the deposition of Brownian particles with electrostatic energy barriers. Langmuir 6:1153-1163.
18. Engel A, Bendas G, Wilhelm F, Mannova M, Ausborn M, Nuhn P (1994): Freeze drying of liposomes with free and membrane-bound cryoprotectants: The background of protection and damaging processes. Int J Pharm 107:99-110.
19. Fessi H, Devissaguet J-P, Puisieux F, Thies C (1992): Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. U.S. patent no. 5118528.
20. Fromtling RA (1988): Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1:187-217.
21. Georgiev VS (1993): Opportunistic/nosocomial infections. Treatment and developmental therapeutics. II. Cryptococcosis. Med Res Rev 13:507-527.
22. Hay RJ (1994): Antifungal therapy of yeast infections. J Am Acad Dermatol 31:S6-S9.
23. Her L-M, Nail SL (1994): Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry. Pharm Res 11:54-49.
24. Hostetler JS, Hanson LH, Stevens DA (1992): Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother 36:477-480.
25. Kauffman CA (1994): Newer developments in therapy for endemic mycoses. Clin Infect Dis 19:S28-S32.
26. Le Conte P, Joly V, Saint-Julien L, Gillardin J-M, Carbon C, Yeni P (1991): Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis. Am Rev Respir Dis 145:424-429.
27. Lopez-Berestein G (1987): Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother 31:675-678.
28. Mehl PM (1995): Effect of pH on the ice crystallization in aqueous solutions of 1,2-propanediol. Consequence for vitrification solutions. Cryo-Lett 16:31-40.
29. Murase N, Echlin P, Franks F (1991): The structural states of freeze-concentrated and freeze-dried phosphates studied by scanning electron microscopy and differential scanning calorimetry. Cryobiology 28:364-375.
30. Nemati F, Cave G, Couvreur P (1992): Approche des problèmes de lyophilisation de substances à faible perméabilité de vapeur par modification de la structure cristallisée au cours de la congélation. Congr Int Technol Pharm 3:487-493.
31. Peng T, Galgiani JN (1993): In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob Agents Chemother 37:2126-2131.
32. Singh M, Singh MP, Maitti SN, Gandhi A, Micetich RG, Atwal H (1993): Preparations of liposomal fluconazole and their in vitro antifungal activity. J Microencapsulation 10:229-236.
33. 99mTc and biodistribution studies. Nucleic Med Biol 22:263-268.
34. Talsma H, van Steenbergen MJ, Crommelin DJA (1991a): The cryopreservation of liposomes. 3. Almost complete retention of a water-soluble marker in small liposomes in a cryoprotectant containing dispersion after a freezing/thawing cycle. Int J Pharm 77:119-126.
35. Talsma H, van Steenbergen MJ, Salemink PJM, Crommelin DJA (1991b): The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing. Pharm Res 8:1021-1026.
36. Talsma H, van Steenbergen MJ, Crommelin DJA (1992): The cryopreservation of liposomes. 2. Effect of particle size on crystallisation behavior and marker retention. Cryobiology 29:80-86.
37. Tanaka K, Takeda T, Fujii K, Miyajima K (1992): Cryoprotective mechanism of saccharides on freeze-drying of liposomes. Chem Pharm Bull 40:1-5.
38. te Booy MPWM, de Ruiter RA, de Meere ALJ (1992). Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry. Pharm Res 9:109-114.
39. Van Doorne H, Bosch EH, Lerk CF (1988): Formation and antimicrobial activity of complexes of β-cyclodextrin and some antimycotic imidazole derivatives. Pharm Weekbl 10:80-85.
40. Wasan KM, Lopez-Berestein G (1995): The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol Immunotoxicol 17:1-15.
41. Zhang MZ, Wen J, Arakawa T, Prestrelski SJ (1995): A new strategy for enhancing the stability of lyophilized protein: The effect of the reconstitution medium on keratinocyte growth factor. Pharm Res 12:1447-1452.